BOLD
Price
$1.14
Change
-$0.04 (-3.39%)
Updated
Aug 7 closing price
Capitalization
25.52M
DSGN
Price
$3.97
Change
-$0.38 (-8.74%)
Updated
Aug 7 closing price
Capitalization
225.37M
89 days until earnings call
Interact to see
Advertisement

BOLD vs DSGN

Header iconBOLD vs DSGN Comparison
Open Charts BOLD vs DSGNBanner chart's image
Boundless Bio
Price$1.14
Change-$0.04 (-3.39%)
Volume$84.08K
Capitalization25.52M
Design Therapeutics
Price$3.97
Change-$0.38 (-8.74%)
Volume$61.87K
Capitalization225.37M
BOLD vs DSGN Comparison Chart in %
Loading...
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLD vs. DSGN commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and DSGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BOLD: $1.14 vs. DSGN: $3.97)
Brand notoriety: BOLD and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 39% vs. DSGN: 68%
Market capitalization -- BOLD: $25.52M vs. DSGN: $225.37M
BOLD [@Biotechnology] is valued at $25.52M. DSGN’s [@Biotechnology] market capitalization is $225.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, BOLD is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 5 TA indicator(s) are bullish while DSGN’s TA Score has 5 bullish TA indicator(s).

  • BOLD’s TA Score: 5 bullish, 4 bearish.
  • DSGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BOLD and DSGN are a good buy in the short-term.

Price Growth

BOLD (@Biotechnology) experienced а -3.80% price change this week, while DSGN (@Biotechnology) price change was +2.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

DSGN is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($225M) has a higher market cap than BOLD($25.5M). DSGN YTD gains are higher at: -35.656 vs. BOLD (-60.690). DSGN has higher annual earnings (EBITDA): -67.79M vs. BOLD (-72.59M). DSGN has more cash in the bank: 230M vs. BOLD (138M). DSGN has less debt than BOLD: DSGN (2.14M) vs BOLD (48.6M). BOLD (0) and DSGN (0) have equivalent revenues.
BOLDDSGNBOLD / DSGN
Capitalization25.5M225M11%
EBITDA-72.59M-67.79M107%
Gain YTD-60.690-35.656170%
P/E Ratio0.16N/A-
Revenue00-
Total Cash138M230M60%
Total Debt48.6M2.14M2,270%
TECHNICAL ANALYSIS
Technical Analysis
BOLDDSGN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
88%
Bullish Trend 2 days ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GFKRF0.04N/A
N/A
Opus One Gold Corp.
TCLAF14.09N/A
N/A
Transcontinental Inc.
VWDRY6.01N/A
-0.08%
Vestas Wind Systems A/S
NTCPF0.91-0.01
-0.87%
Northisle Copper and Gold Inc.
BECTY8.61-0.19
-2.16%
Bechtle AG

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with IPSC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
-3.39%
IPSC - BOLD
39%
Loosely correlated
-2.43%
DSGN - BOLD
39%
Loosely correlated
-8.74%
OCUL - BOLD
37%
Loosely correlated
-1.60%
DNLI - BOLD
36%
Loosely correlated
-0.42%
HLVX - BOLD
36%
Loosely correlated
+0.49%
More

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-8.74%
VRDN - DSGN
49%
Loosely correlated
-3.90%
IDYA - DSGN
49%
Loosely correlated
-5.16%
AURA - DSGN
46%
Loosely correlated
-1.21%
TRDA - DSGN
46%
Loosely correlated
-10.92%
NTLA - DSGN
45%
Loosely correlated
+0.88%
More